期刊文献+

康复新雾化吸入防治鼻咽癌放射相关口腔黏膜损伤的时机 被引量:2

Opportunity choice of therapeutic effects of Kangfuxing fluid spray inhalation in the radiotherapy of na-sopharyngeal carcinoma related mucous membrane of mouth
下载PDF
导出
摘要 目的探讨康复新原液雾化吸入在防治鼻咽癌放射性黏膜损伤的参与时机。方法选取本院2009年5月至2012年5月收治的60例放疗期间接受康复新雾化吸入的鼻咽癌患者的临床资料进行分析。60例病例有23例康复新原液雾化吸入参与时间为放疗0次,19例为放疗10次、18例为放疗15次,康复新雾化吸入应用方法10ml/次,3次/d。结果康复新雾化吸入放疗0次、10次参与放射性口腔黏膜炎症显著轻于放疗15次参与,放疗0次、放疗10次参与对防治放射性口腔黏膜炎症无差异。结论康复新原液雾化吸入在防治放射相关口腔黏膜损伤的最佳参与时间为放疗10次,放射相关口腔黏膜炎症轻,放疗耐受性好,过早参与不能明显减轻炎症,且增加患者花费及心理负担,过晚参与放射相关口腔黏膜损伤程度重,放疗耐受性差,甚至导致放疗中断。 Objective To explore the opportunity choice of therapeutic effects of Kangfuxing Fluid spray inhalation in the radiotherapy of nasopharyngeal carcinoma related mucous membrane of mouth. Methods Clinical data of 60 cases of nasopharyngeal carcinoma received radiotherapy and Kangfuxing Fluid spray inha-lation,from May 2009 to May 2012,were collected and analysed retrospectively. Among which,23 case were re-ceived Kangfuxing Fluid spray inhalation at the beginning of radiotherapy,19 case received at the 10th of radio-therapy,18 case at the 15th. Application method of Kangfuxing Fluid spray inhalation: 10 ml one time,3 times a day. Results Therapeutic effects of Kangfuxing Fluid spray inhalation of the case received Kangfuxing Fluid spray inhalation at the beginning and the 10th were significantly better than the case at the 15th,but the case re-ceived Kangfuxing Fluid spray inhalation at the beginning and the 10th have not statistically significant differ-ence. Conculsion The best opportunity choice of therapeutic effects of Kangfuxing Fluid spray inhalation is at the 10th of nasopharyngeal carcinoma radiotherapy.
出处 《中国实用医药》 2013年第18期28-29,共2页 China Practical Medicine
关键词 康复新原液 鼻咽癌 放射相关 口腔黏膜炎症 Kangfuxing Fluid Spray Inhalation Nasopharyngeal carcinoma radiotherapy Mucous membrane of mouth
  • 相关文献

参考文献7

二级参考文献45

  • 1放射性口腔炎诊断标准[J].中国农村医学杂志,2005,3(5):61-62. 被引量:18
  • 2赵充,卢泰祥,韩非,卢丽霞,黄劭敏,邓小武,林承光,崔念基.139例鼻咽癌调强放疗的临床研究[J].中华放射肿瘤学杂志,2006,15(1):1-6. 被引量:154
  • 3郑远达,闻强,季永领,秦卫丰,周晓君.康复新液防治放疗患者口腔黏膜急性放射损伤的观察[J].华西药学杂志,2006,21(4):404-404. 被引量:66
  • 4Kam M K, Teo P M, Chan R M, et al. Treatment of nasopha- ryngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong experience [J]. Int J Radiat Oncol Biol Phys, 2004, 60(5) : 1440-1450.
  • 5Vera-Llonch M, Oster G, Hagiwara M, et al. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma [J]. Cancer, 2006,106(2) :329-336.
  • 6Nakamura Y, Feng Q, Kumagai T, et al. Ebselen, a glutathione peroxidase mime-tic seleno-organic compound, as a multifunc- tional antioxidant. Imphcation for inflammation-associated car- cinogenesis [J]. J Biol Chem, 2002,277(4):2687-2694.
  • 7张惠兰.肿瘤化学治疗的护理[A].见:孙燕主编.内科肿瘤学[C].北京:人民卫生出版社,2001.341.
  • 8Kam MK, Chau RM, Suen J, et al. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation[J].Int J Radiat Oncol Biol Phys. 2003,56(1):145-57.
  • 9Hsiung CY, Yorke ED, Chui CS, et al. Intensity-modulated radiotherapy versus conventional three-dimensional conformal radiotherapy for boost or salvage treatment of nasopharyngeal carcinoma[J].Int J Radiat Oncol Biol Phys, 2002,53(3):638-647.
  • 10Farias TP, Dias FL, Lima RA, et. al. Prognostic factors and outcome for nasopharyngeal carcinoma[J].Arch Otolaryngol Head Neck Surg, 2003,129(7):794-799.

共引文献73

同被引文献2

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部